title: Neonatal astrocyte damage is sufficient to trigger progressive striatal degeneration in a rat model of glutaric acidemia-I.
abstract: BACKGROUND
  We have investigated whether an acute metabolic damage to astrocytes during the neonatal period may critically disrupt subsequent brain development, leading to neurodevelopmental disorders. Astrocytes are vulnerable to glutaric acid (GA), a dicarboxylic acid that accumulates in millimolar concentrations in Glutaric Acidemia I (GA-I), an inherited neurometabolic childhood disease characterized by degeneration of striatal neurons. While GA induces astrocyte mitochondrial dysfunction, oxidative stress and subsequent increased proliferation, it is presently unknown whether such astrocytic dysfunction is sufficient to trigger striatal neuronal loss.
  
  
  RESULTS
  A single intracerebroventricular dose of GA was administered to rat pups at postnatal day 0 (P0) to induce an acute, transient rise of GA levels in the central nervous system (CNS). GA administration potently elicited proliferation of astrocytes expressing S100β followed by GFAP astrocytosis and nitrotyrosine staining lasting until P45. Remarkably, GA did not induce acute neuronal loss assessed by FluoroJade C and NeuN cell count. Instead, neuronal death appeared several days after GA treatment and progressively increased until P45, suggesting a delayed onset of striatal degeneration. The axonal bundles perforating the striatum were disorganized following GA administration. In cell cultures, GA did not affect survival of either striatal astrocytes or neurons, even at high concentrations. However, astrocytes activated by a short exposure to GA caused neuronal death through the production of soluble factors. Iron porphyrin antioxidants prevented GA-induced astrocyte proliferation and striatal degeneration in vivo, as well as astrocyte-mediated neuronal loss in vitro.
  
  
  CONCLUSIONS
  Taken together, these results indicate that a transient metabolic insult with GA induces long lasting phenotypic changes in astrocytes that cause them to promote striatal neuronal death. Pharmacological protection of astrocytes with antioxidants during encephalopatic crisis may prevent astrocyte dysfunction and the ineluctable progression of disease in children with GA-I.
authors.affiliation: Cellular and Molecular Neurobiology Department, Instituto Clemente Estable, Montevideo, Uruguay.
authors.forename: Silvia
authors.initials: S
authors.lastname: Olivera-Bravo
authors.forename: Anabel
authors.initials: A
authors.lastname: Fernández
authors.forename: María Noel
authors.initials: MN
authors.lastname: Sarlabós
authors.forename: Juan Carlos
authors.initials: JC
authors.lastname: Rosillo
authors.forename: Gabriela
authors.initials: G
authors.lastname: Casanova
authors.forename: Marcie
authors.initials: M
authors.lastname: Jiménez
authors.forename: Luis
authors.initials: L
authors.lastname: Barbeito
mesh_terms: D000592:Amino Acid Metabolism, Inborn Errors / Q000473:pathology*; D000818:Animals; D000831:Animals, Newborn; D001253:Astrocytes / Q000473:pathology*; D001928:Brain Diseases, Metabolic / Q000473:pathology*; D003342:Corpus Striatum / Q000473:pathology*; D018450:Disease Progression; D050770:Glutaryl-CoA Dehydrogenase / Q000172:deficiency; D051381:Rats
chemical_list: D050770:Glutaryl-CoA Dehydrogenase